Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

The themes explored in this book began with a paper written by two of the authors (Russo
and Williamson 2007), which set out the core idea of evidential pluralism in the context of …

This document provides the new EANM guideline on radioiodine therapy of benign thyroid
disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners …

This article reviews agreement, disagreement and need for future research of the thyroid
nodule guidelines published by the British Thyroid Association, National Cancer Institute …

Systematic reviews of high quality randomized trials generally count as the 'best evidence'. 1
However, well-conducted randomized trials are sometimes unavailable, 2, 3 unfeasible, 4 …

Goiters tend to grow slowly and steadily over many years, occasionally reaching the
mediastinum and extending through the thoracic inlet into the visceral compartment. In most …

The new management guidelines of the American Thyroid Association (ATA) and American
Association of Clinical Endocrinologists (AACE) for the management of hyperthyroidism and …

Thyroid nodules are common. Thyroid cancer is rarer. No guidelines exist for management
of thyroid nodules in the Indian context and these recommendations are intended for this …

Part 2 of this series of Continuing Education articles on benign thyroid disorders deals with
nodular goiter, hypothyroidism, and subacute thyroiditis. Together with Part 1 (which dealt …

The treatment of benign multinodular goitre (MNG) is controversial, but surgery is
recommended in large compressive goitres. While some patients decline surgery others …